Ascorbic Acid Suppresses House Dust Mite-Induced Expression of Interleukin-8 in Human Respiratory Epithelial Cells

An Jun Lee1, Joo Weon Lim1, Hyeyoung Kim1

  • 1Department of Food and Nutrition, BK 21 FOUR, College of Human Ecology, Yonsei University, Seoul, Korea.

Insights

House dust mite (HDM) triggers airway inflammation by increasing oxidative stress and releasing interleukin-8 (IL-8). Ascorbic acid combats this by reducing reactive oxygen species (ROS) and inhibiting inflammatory pathways.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • House dust mite (HDM) is a major allergen triggering airway inflammation, including asthma.
  • HDM induces oxidative stress and the release of chemokines like interleukin-8 (IL-8) in the lungs.
  • Reactive oxygen species (ROS) activate inflammatory signaling pathways, including mitogen-activated protein kinases (MAPKs) and transcription factors NF-κB and AP-1.

Purpose of the Study:

  • To investigate if HDM induces IL-8 expression via MAPK, NF-κB, and AP-1 activation.
  • To determine if ascorbic acid inhibits HDM-stimulated IL-8 expression by reducing ROS and suppressing these signaling pathways.
  • To examine the effects in the H292 respiratory epithelial cell line.

Main Methods:

  • H292 cells were treated with HDM (5 μg/mL).
  • Ascorbic acid (100 or 200 μM) was administered in the presence or absence of HDM.
  • ROS levels, MAPK, NF-κB, AP-1 activation, and IL-8 expression were measured.

Main Results:

  • HDM treatment significantly increased ROS levels, activated MAPKs, NF-κB, and AP-1, leading to elevated IL-8 expression.
  • Ascorbic acid administration effectively reduced ROS levels in HDM-treated cells.
  • Ascorbic acid inhibited the activation of MAPKs, NF-κB, and AP-1, consequently suppressing IL-8 production.

Conclusions:

  • HDM induces respiratory inflammation through oxidative stress-mediated activation of MAPK, NF-κB, and AP-1 signaling pathways.
  • Ascorbic acid demonstrates potent antioxidant and anti-inflammatory effects by inhibiting these pathways.
  • Dietary intake of ascorbic acid-rich foods may help prevent HDM-mediated respiratory inflammation.

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.5K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
927
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.0K
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.3K
Antiasthma Drugs: Muscarinic Receptor Antagonists01:20

Antiasthma Drugs: Muscarinic Receptor Antagonists

Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
1.4K